Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

View:
Post by ENEMENEMYNEMO on Oct 06, 2024 9:51pm

Wow

Wow big jump on the news. Shucks I should have waited to sell.  Good luck to ya'll... pity about the patent though...20 months left... best find some cash and start the study soon!!
Comment by canadafan on Oct 07, 2024 12:50am
First, you are way off base with the patent. Once again spewing ninesense.lthe patents minimum until 2030. as co- therapy, a totally new venture. yes, lots LIF new institutions. the silly fools leloing in panic, nit understanding " buy low, sell high" regardeles of that, the scienc3 and now published expectations of getting accelerated approval oppotunities, great many doors just opened ...more  
Comment by Peladawn on Oct 07, 2024 9:55am
ENEMENEMENUMBRAIN..pity you didnt cover those shorts!.lol!
Comment by canadafan on Oct 07, 2024 10:20am
Last short squeeze was very similar. Yet 5 yrs ago. Went from under $1 to over $5 in a few weeks. This time IS Different! They are in writing talking about accelerated approval. THAT , is the brass ring for onc. Any approval, would move oncolytics biotech from development stage to marketing stage. Going back 5 yrs, only had expectations of outcomes. Now, the pancreatic cancer co therapy alone ...more  
Comment by CMHarring218431 on Oct 07, 2024 10:30am
Yes! Just reread the PR. Just really impressive. Like a few have said....it reads very well. All the data is presented in a smooth manner that is equally easy to follow and understand. Fantastic job ONCY
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities